Desogestrel: using a selective progestogen in a combined oral contraceptive

@article{Berg1991DesogestrelUA,
  title={Desogestrel: using a selective progestogen in a combined oral contraceptive},
  author={M. Berg},
  journal={Advances in Contraception},
  year={1991},
  volume={7},
  pages={241-250}
}
  • M. Berg
  • Published 1 June 1991
  • Medicine
  • Advances in Contraception
Desogestrel is the most selective progestogen used in oral contraceptives (OCs). The clinical characteristics of the monophasic combined OC containing 150 μg desogestrel and 30 μg EE per tablet (Marvelon) are in accordance with the strong progestogenic and minimal androgenic effects of desogestrel: a very high contraceptive efficacy is combined with minimal and, in the case of lipid metabolism, even potentially positive effects on metabolic parameters.Through increasing the plasma levels of sex… 
3 Citations
Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
Thirty healthy women, aged 18 to 37, were randomly allocated to treatment with a desogestrel-containing oral contraceptive, with 20 women using a nine-week on, one-week off regimen, and 10 women
Androgenic disorders of women: diagnostic and therapeutic decision making.
  • G. Redmond
  • Medicine
    The American journal of medicine
  • 1995
TLDR
Overall, medical therapy of androgenic disorders is more effective than generally recognized and the principal pitfalls are failing to select medication based on the specific endocrine disturbance and failing to wait long enough for improvement to appear.

References

SHOWING 1-10 OF 36 REFERENCES
The new generation of monophasic oral contraceptives.
TLDR
Because OCs are used for prolonged periods the new monophasic OCs offer more safety reliability and acceptability than those OCs that contain more androgenic properties.
Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism.
The effects of the monophasic oral contraceptive preparation desogestrel plus ethinyloestradiol (EE) and triphasic levonorgestrel plus EE on lipid metabolism were compared. Sixteen young healthy
Multicenter Trial of a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and Desogestrel
  • H. Rekers
  • Medicine
    Acta obstetricia et gynecologica Scandinavica
  • 1988
TLDR
The combination (Marvelon) was shown to be a very reliable and acceptable oral contraceptive and cycle control was excellent, with decreases in the duration and amount of withdrawal bleeding during consecutive treatment cycles and a low incidence of irregular bleeding.
OVULATION INHIBITION WITH DIFFERENT DOSES OF LEVONORGESTREL * AND OTHER PROGESTOGENS: CLINICAL AND EXPERIMENTAL INVESTIGATIONS
TLDR
The present data combine to suggest that all model system are efficient to evaluate new progestogens, and that δ15‐levonorgestrel exerts a some 3‐times greater biological activity than levonorgESTrel itself, which suggests a dose reduction of the progestogen component in oral contraceptives seems to be possible.
A new low-dose estrogen oral contraceptive combination: effect on endocrine parameters and lipid status.
TLDR
The significant increase of SHBG and the corresponding reduction of free testosterone reflect the estrogenic environment of this pill and the low androgenicity of desogestrel.
The influence of the triphasic pill and a desogestrel-containing combination pill on some physical, biochemical and hormonal parameters: a preliminary report
TLDR
It is concluded that the observed changes in biochemical and hormonal parameters are minor and only reach the level of significance in the desogestrel group.
Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.
A multicenter trial was conducted in 267 centers in Italy to evaluate the efficacy, acceptability and safety of a monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 150
The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins.
TLDR
The results indicate that both progestins induced the same 'androgenic' pattern when given alone and in combination with EE, however, DG seems to counteract the effects of EE to a lesser extent than NORG, as judged particularly from the effects on TG and PL in serum and VLDL.
Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
TLDR
The triphasic OC containing low doses of LNG does not induce obvious, clinically significant, alterations of lipid metabolism, and this is also the case for the low-dose monophasic combination of EE + DOG.
Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
TLDR
Both preparations induced similar changes in the levels of lipids and lipoproteins with the exception of a significant increase in the arachidonic content of cholesterol during treatment with the desogestrel-containing preparation.
...
1
2
3
4
...